Alzheimer’s cure behind the boom in brain science (Financial Review):
“Biogen is one of many members of big pharma seeking the blockbuster drug which will inevitably be worth multiple billions of dollars. Big pharma in the US spends about $US5 billion a year on Alzheimer’s research and development.
Exponential growth in the disease over the past decade has not been accompanied by the development of approved drugs. In fact, [Read more…] about Can better cognitive testing platforms accelerate pharma’s Alzheimer’s research and development efforts?